Mounjaro®
Starting from £179.99/mo
Start journey Learn moreYour first Mounjaro pen has arrived. You know the injection is once a week and starts at 2.5mg, but the questions are piling up: when exactly should you take it, where does it go, and will it actually work? Starting Mounjaro — tirzepatide, Eli Lilly's dual GIP and GLP-1 receptor agonist licensed in the UK for weight management — is straightforward once you know what each step is for. This guide covers the process honestly, from that first injection to what the early weeks feel like, drawing on NHS guidance on tirzepatide. As a prescription-only medicine, Mounjaro requires a clinical assessment before you begin; a prescriber decides whether it is suitable for you and at what starting point.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Most people feel a mixture of relief and mild anxiety at this point. That is completely normal for anyone starting an injectable medicine for the first time. Take a few minutes to read through the Patient Information Leaflet that came with your pen; it contains storage instructions and injection technique specific to the KwikPen format Mounjaro comes in.
Before the injection itself, check that the liquid is clear and colourless. Let the pen reach room temperature, your leaflet will tell you the exact duration; do not guess this. Clean the injection site with an alcohol swab and let it dry completely before you press the pen against your skin. Mounjaro is injected subcutaneously into the fatty layer beneath the skin, not into muscle, so a relaxed site and a consistent 90-degree angle matter.
Choose your injection day deliberately. Many people pick a day that is not the busiest of their week, because nausea (if it arrives at all) often peaks in the 24 to 48 hours after the injection. A Thursday or Friday injection, for example, means any settling-in discomfort lands over a weekend rather than a work morning. You do not have to take it at the same time of day, but the same day each week is important for consistency.
The first pen's job is adjustment, not treatment. At 2.5mg your body is being introduced to the medicine; appetite reduction and meaningful weight change come later, as the dose increases under your prescriber's guidance. This is worth knowing because some people feel discouraged when nothing dramatic happens in week one. That is the design, not a failure.
Tirzepatide activates two gut-hormone receptors (GIP and GLP-1) which together slow gastric emptying, increase the sensation of fullness and influence appetite signals in the brain. At 2.5mg, those effects are present but gentle; they ramp up as titration progresses, typically in four-week steps. In the SURMOUNT-1 clinical trial, involving 2,539 adults, the highest doses produced average body-weight reductions of around 20–21% over 72 weeks, but those results followed months of gradual titration, not the first pen.
If you want a fuller picture of what the clinical evidence shows, the timeline for when Mounjaro starts to work covers it week by week. Understanding the titration process also helps you choose the right time to begin relative to your schedule and goals.
Gastrointestinal symptoms are the most reported early experience: nausea, loose stools, constipation, indigestion, sometimes burping. They are not universal (many people get through the first weeks without significant difficulty) but they are common enough that planning for them is sensible. Slow eating, smaller portions, choosing lower-fat foods and staying well hydrated all help. NHS tirzepatide guidance suggests avoiding rich or spicy meals while you are adjusting, particularly in the first days after a dose change.
Side effects typically ease as your body adapts. Most people find the worst of the nausea settles within one to two weeks of a new dose. If symptoms are severe or persistent, your prescriber needs to know; reducing the pace of titration is a legitimate clinical option. One thing to watch: inadequate protein and fluid intake during this period can compound fatigue. Eating enough protein at each meal, even when appetite is low, supports muscle retention alongside fat loss.
A note on cost: if you are weighing up whether Mounjaro is financially sustainable before committing to the adjustment phase, the Mounjaro cost and pricing page sets out what private treatment typically involves in the UK.
Mounjaro is a Black Triangle medicine (▼), meaning it carries additional MHRA monitoring. That is standard for newer licensed medicines and does not mean it is unsafe, it means post-market data is actively collected. You can contribute to that by reporting any side effect that concerns you through the MHRA Yellow Card scheme.
There are specific symptoms that need prompt medical attention: severe or persistent stomach pain that extends to the back (a possible indicator of pancreatitis), signs of an allergic reaction, or symptoms of gallbladder problems such as sharp upper-right abdominal pain. Contact a healthcare professional or call 111 if these occur. For guidance on taking Mounjaro correctly, including rotating injection sites and handling missed doses, your Patient Information Leaflet is the first place to check, with your prescriber the right person for anything beyond what it covers.
If you are considering starting treatment and have not yet had a clinical assessment, finding out how to start Mounjaro covers what the process involves before the process at nume begins with a free consultation reviewed by a GPhC-registered prescriber, the same day, with no algorithm in between. For more background on tirzepatide itself before you decide, the tirzepatide overview covers the mechanism, licensing and evidence in detail.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.